Cargando…

Biological and Molecular Effects of Small Molecule Kinase Inhibitors on Low-Passage Human Colorectal Cancer Cell Lines

Low-passage cancer cell lines are versatile tools to study tumor cell biology. Here, we have employed four such cell lines, established from primary tumors of colorectal cancer (CRC) patients, to evaluate effects of the small molecule kinase inhibitors (SMI) vemurafenib, trametinib, perifosine, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lange, Falko, Franz, Benjamin, Maletzki, Claudia, Linnebacher, Michael, Hühns, Maja, Jaster, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182691/ https://www.ncbi.nlm.nih.gov/pubmed/25309914 http://dx.doi.org/10.1155/2014/568693

Ejemplares similares

Colorectal carcinoma tumour budding and podia formation in the xenograft microenvironment
por: Prall, Friedrich, et al.
Publicado: (2017)

The mutational profile and infiltration pattern of murine MLH1(-/-) tumors: concurrences, disparities and cell line establishment for functional analysis
por: Maletzki, Claudia, et al.
Publicado: (2016)

Studies on Biological and Molecular Effects of Small-Molecule Kinase Inhibitors on Human Glioblastoma Cells and Organotypic Brain Slices
por: Hörnschemeyer, Julia, et al.
Publicado: (2022)

Direct-Current Electrical Field Stimulation of Patient-Derived Colorectal Cancer Cells
por: Lange, Falko, et al.
Publicado: (2023)

Murine Endogenous Retroviruses Are Detectable in Patient-Derived Xenografts but Not in Patient-Individual Cell Lines of Human Colorectal Cancer
por: Bock, Stephanie, et al.
Publicado: (2018)

Application of in vivo imaging techniques to monitor therapeutic efficiency of PLX4720 in an experimental model of microsatellite instable colorectal cancer
por: Rohde, Sarah, et al.
Publicado: (2017)

Establishment, Characterization and Chemosensitivity of Three Mismatch Repair Deficient Cell Lines from Sporadic and Inherited Colorectal Carcinomas
por: Maletzki, Claudia, et al.
Publicado: (2012)

Targeting Immune-Related Molecules in Cancer Therapy: A Comprehensive In Vitro Analysis on Patient-Derived Tumor Models
por: Maletzki, Claudia, et al.
Publicado: (2019)

Tumor-infiltrating B cells: The ignored players in tumor immunology
por: Linnebacher, Michael, et al.
Publicado: (2012)

Streptococcus gallolyticus abrogates anti-carcinogenic properties of tannic acid on low-passage colorectal carcinomas
por: Oehmcke-Hecht, Sonja, et al.
Publicado: (2020)

Host defense peptides for treatment of colorectal carcinoma – a comparative in vitro and in vivo analysis
por: Maletzki, Claudia, et al.
Publicado: (2014)

Cryopreservation of human colorectal carcinomas prior to xenografting
por: Linnebacher, Michael, et al.
Publicado: (2010)

Generation, Characterization and Application of Antibodies Directed against HERV-H Gag Protein in Colorectal Samples
por: Mullins, Christina S., et al.
Publicado: (2016)

Integrated Biobanking and Tumor Model Establishment of Human Colorectal Carcinoma Provides Excellent Tools for Preclinical Research
por: Mullins, Christina S., et al.
Publicado: (2019)

Ex-vivo Clonally Expanded B Lymphocytes Infiltrating Colorectal Carcinoma Are of Mature Immunophenotype and Produce Functional IgG
por: Maletzki, Claudia, et al.
Publicado: (2012)

An MSI Tumor Specific Frameshift Mutation in a Coding Microsatellite of MSH3 Encodes for HLA-A0201-Restricted CD8(+) Cytotoxic T Cell Epitopes
por: Garbe, Yvette, et al.
Publicado: (2011)

Microsatellite instability in hematological malignancies: Hypermutation vs. immune control—who is challenging who?
por: Maletzki, Claudia, et al.
Publicado: (2013)

Establishment, characterization, and drug screening of low-passage patient individual non-small cell lung cancer in vitro models including the rare pleomorphic subentity
por: Andus, Ingo, et al.
Publicado: (2023)

Bacterial immunotherapy of gastrointestinal tumors
por: Linnebacher, Michael, et al.
Publicado: (2011)

Combinations of TLR Ligands: A Promising Approach in Cancer Immunotherapy
por: Stier, Saskia, et al.
Publicado: (2013)

Functional Characterization and Drug Response of Freshly Established Patient-Derived Tumor Models with CpG Island Methylator Phenotype
por: Maletzki, Claudia, et al.
Publicado: (2015)

Expression of young HERV-H loci in the course of colorectal carcinoma and correlation with molecular subtypes
por: Pérot, Philippe, et al.
Publicado: (2015)

Decoding kinase-adverse event associations for small molecule kinase inhibitors
por: Gong, Xiajing, et al.
Publicado: (2022)

Small molecule tyrosine kinase inhibitors in pancreatic cancer
por: Gupta, Sachin, et al.
Publicado: (2008)

An Update on Development of Small-Molecule Plasmodial Kinase Inhibitors
por: Moolman, Chantalle, et al.
Publicado: (2020)

Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer
por: Viganò, Mauro, et al.
Publicado: (2023)

Characterization of novel low passage primary and metastatic colorectal cancer cell lines
por: Boot, Arnoud, et al.
Publicado: (2016)

Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines
por: Phillip, Cornel Joseph, et al.
Publicado: (2013)

Prediction of specificity-determining residues for small-molecule kinase inhibitors
por: Caffrey, Daniel R, et al.
Publicado: (2008)

Mechanism and consequences of RAF kinase activation by small-molecule inhibitors
por: Holderfield, M, et al.
Publicado: (2014)

Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase
por: Moccia, Marialuisa, et al.
Publicado: (2015)

Impact of Selected Small-Molecule Kinase Inhibitors on Lipid Membranes
por: Luck, Meike, et al.
Publicado: (2021)

Parameter Identifiability and Sensitivity Analysis Predict Targets for Enhancement of STAT1 Activity in Pancreatic Cancer and Stellate Cells
por: Rateitschak, Katja, et al.
Publicado: (2012)

Cyclin-Dependent Kinase Inhibitors in Hematological Malignancies—Current Understanding, (Pre-)Clinical Application and Promising Approaches
por: Richter, Anna, et al.
Publicado: (2021)

Erratum to: Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines
por: Phillip, Cornel Joseph, et al.
Publicado: (2016)

Reevaluating the Concept of Treating Experimental Tumors with a Mixed Bacterial Vaccine: Coley's Toxin
por: Maletzki, C., et al.
Publicado: (2012)

Potential of Small Molecule Protein Tyrosine Kinase Inhibitors as Immunomodulators and Inhibitors of the Development of Diabetes
por: Little, Peter J., et al.
Publicado: (2009)

Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin
por: Huertas, D, et al.
Publicado: (2012)

Radiolabeled Small Molecule Protein Kinase Inhibitors for Imaging with PET or SPECT
por: Hicks, Justin W., et al.
Publicado: (2010)

Small molecule inhibitors of cyclin-dependent kinase 9 for cancer therapy
por: Alsfouk, Aisha
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ikj9tb9j174hokv2lan4kelcmm